(3-fluoro-4-methoxyphenyl)-[2-[3-methoxy-4-(1H-pyrazol-4-yl)phenyl]-2,8-diazaspiro[4.5]decan-8-yl]methanone
C26H29FN4O3 — CID 155092670
Data last refreshed: (MolForge compound catalog, from PubChem)
About (3-fluoro-4-methoxyphenyl)-[2-[3-methoxy-4-(1H-pyrazol-4-yl)phenyl]-2,8-diazaspiro[4.5]decan-8-yl]methanone
(3-fluoro-4-methoxyphenyl)-[2-[3-methoxy-4-(1H-pyrazol-4-yl)phenyl]-2,8-diazaspiro[4.5]decan-8-yl]methanone (PubChem CID 155092670) has the molecular formula C26H29FN4O3 and a molecular weight of 464.54 g/mol. Its IUPAC name is (3-fluoro-4-methoxyphenyl)-[2-[3-methoxy-4-(1H-pyrazol-4-yl)phenyl]-2,8-diazaspiro[4.5]decan-8-yl]methanone.
Molecular Properties
| Compound Name | (3-fluoro-4-methoxyphenyl)-[2-[3-methoxy-4-(1H-pyrazol-4-yl)phenyl]-2,8-diazaspiro[4.5]decan-8-yl]methanone |
|---|---|
| PubChem CID | 155092670 |
| Molecular Formula | C26H29FN4O3 |
| Molecular Weight | 464.54 g/mol |
| Exact Mass | 464.22 |
| IUPAC Name | (3-fluoro-4-methoxyphenyl)-[2-[3-methoxy-4-(1H-pyrazol-4-yl)phenyl]-2,8-diazaspiro[4.5]decan-8-yl]methanone |
| SMILES | COc1ccc(C(=O)N2CCC3(CC2)CCN(c2ccc(-c4cn[nH]c4)c(OC)c2)C3)cc1F |
| InChI | InChI=1S/C26H29FN4O3/c1-33-23-6-3-18(13-22(23)27)25(32)30-10-7-26(8-11-30)9-12-31(17-26)20-4-5-21(24(14-20)34-2)19-15-28-29-16-19/h3-6,13-16H,7-12,17H2,1-2H3,(H,28,29) |
| InChIKey | PBPYUGVFAKZCIM-UHFFFAOYSA-N |
| XLogP | 4.37 |
| TPSA | 70.69 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 5 |
| Rotatable Bonds | 5 |
| Heavy Atoms | 34 |
| Complexity | — |
Lipinski Rule of Five
Passes Rule of Five
| Rule | Value |
|---|---|
| MW ≤ 500 | 464.54 |
| LogP ≤ 5 | 4.37 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 5 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 155092670 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.